Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Mahfoud

Showing results (491-500 of 614) with videos related to

Pageof 62
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 24, 2025
Time- and dose-dependent high-sensitivity cardiac troponin-T to improve outcome prediction after TAVI: a multicenter cohort studyThorald Stolte, Jakob Johannes Reichl, Pedro Lopez-Ayala, et al.
Journal of Hypertension|July 15, 2021
European Society of Hypertension position paper on renal denervation 2021Roland E Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
European Journal of Preventive Cardiology|July 18, 2025
Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reportsFelix Mahfoud, David E Kandzari, Markus P Schlaich, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 8, 2021
Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trialFelix Mahfoud, Michael J Bloch, Michel Azizi, et al.
European Heart Journal|November 7, 2022
Hypertension management in patients with cardiovascular comorbiditiesLucas Lauder, Felix Mahfoud, Michel Azizi, et al.
Lancet (London, England)|May 28, 2018
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E Kandzari, Michael Böhm, Felix Mahfoud, et al.
American Heart Journal|December 26, 2025
Large-bore mechanical thrombectomy vs standard of care for acute high-risk pulmonary embolism: rationale and design of the PERSEVERE randomized controlled trialRomain Chopard, Lukas Hobohm, Stefano Barco, et al.
Journal of Hypertension|March 2, 2011
Renal denervation: a potential new treatment modality for polycystic ovary syndrome?Markus P Schlaich, Nora Straznicky, Mariee Grima, et al.
The American Journal of Cardiology|February 9, 2026
Radial versus femoral secondary access in patients undergoing TAVI - Rationale and Design of the RADIAL-TAVI trialAlexander von Ehr, Uwe Zeymer, Steffen Schneider, et al.
European Heart Journal|December 28, 2018
Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Pageof 62

Showing results (491-500 of 614) with videos related to

Sort By:
Pageof 62
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 24, 2025
Time- and dose-dependent high-sensitivity cardiac troponin-T to improve outcome prediction after TAVI: a multicenter cohort studyThorald Stolte, Jakob Johannes Reichl, Pedro Lopez-Ayala, et al.
Journal of Hypertension|July 15, 2021
European Society of Hypertension position paper on renal denervation 2021Roland E Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
European Journal of Preventive Cardiology|July 18, 2025
Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reportsFelix Mahfoud, David E Kandzari, Markus P Schlaich, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 8, 2021
Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trialFelix Mahfoud, Michael J Bloch, Michel Azizi, et al.
European Heart Journal|November 7, 2022
Hypertension management in patients with cardiovascular comorbiditiesLucas Lauder, Felix Mahfoud, Michel Azizi, et al.
Lancet (London, England)|May 28, 2018
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E Kandzari, Michael Böhm, Felix Mahfoud, et al.
American Heart Journal|December 26, 2025
Large-bore mechanical thrombectomy vs standard of care for acute high-risk pulmonary embolism: rationale and design of the PERSEVERE randomized controlled trialRomain Chopard, Lukas Hobohm, Stefano Barco, et al.
Journal of Hypertension|March 2, 2011
Renal denervation: a potential new treatment modality for polycystic ovary syndrome?Markus P Schlaich, Nora Straznicky, Mariee Grima, et al.
The American Journal of Cardiology|February 9, 2026
Radial versus femoral secondary access in patients undergoing TAVI - Rationale and Design of the RADIAL-TAVI trialAlexander von Ehr, Uwe Zeymer, Steffen Schneider, et al.
European Heart Journal|December 28, 2018
Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Pageof 62